Concepedia

Michał Mlącki

MM

Statistics

Publications

10

Citations

276

H-Index

10

Active since

2014

Affiliations

Medical University of Warsaw(Current)

OncoArendi Therapeutics (Poland)

Postgraduate School of Molecular Medicine

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego

Erasmus MC

Michał Mlącki is an author at Medical University of Warsaw specializing in medicine, pharmacology, and innate immunity.

ORCID

Publications per year

2014–2025

10

Publications

10

Loss of Grainy Head-Like 1 Is Associated with Disruption of the Epidermal Barrier and Squamous Cell Carcinoma of the Skin

Michał Mlącki, Charbel Darido, Stephen M. Jane et al. · PLoS ONE · 2014 · 65 citations · Full text

, , +17

OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer

Marcin Grzybowski, Paulina Seweryna Stańczak, Paulina Pomper et al. · Cancers · 2022 · 37 citations · Full text

, , +11

Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis

Piotr Sklepkiewicz, Barbara Dymek, Michał Mlącki et al. · European Journal of Pharmacology · 2022 · 31 citations · Full text

, , +15

Discovery of <b>OATD-01</b>, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis

Robert Koralewski, Barbara Dymek, Marzena Mazur et al. · Journal of Medicinal Chemistry · 2020 · 29 citations · Full text

, , +7

Epithelial-macrophage-dendritic cell interactions impact alarmins expression in asthma and COPD

Magdalena Paplińska‐Goryca, Paulina Misiukiewicz‐Stępień, Patrycja Nejman‐Gryz et al. · Clinical Immunology · 2020 · 27 citations · Full text

, , +17

1–5 of 10